The evaluated PNPLA3 and FGF21 SNPs were not associated with NAFLD among T2D patients, but the PNPLA3 GG genotype carriers had higher GGT and AST values compared to the other genotypes, and higher TE LSM values than the CG carriers. This evidence concerns the gene FGF21 and metabolic dysfunction-associated steatotic liver disease.